Ernesto Paolasso

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

Robert T. Collins, R Peto, Marcus Flather et al. · Ghent University Academic Bibliography (Ghent University) · 1995 · 1.1K citations

Thrombosis, Cardiovascular Disease, Pharmacotherapy +8

Vorapaxar in the Secondary Prevention of Atherothrombotic Events

David A. Morrow, Eugene Braunwald, Marc P. Bonaca et al. · New England Journal of Medicine · 2012 · 927 citations · Full text

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

D Hunt, George Varigos, F Dienstl et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1992 · 898 citations

Thrombosis, Cardiovascular Disease, Cardiology +8

Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days

André Lamy, P.J. Devereaux, Dorairaj Prabhakaran et al. · New England Journal of Medicine · 2012 · 686 citations · Full text